Patents by Inventor Kenneth M. Yates
Kenneth M. Yates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11739017Abstract: A method of treating oil and gas produced water may include: receiving produced water from one or more wells; separating an aqueous portion of the produced water from oil and solids included in the produced water in order to provide recovered water; performing anaerobic bio-digestion of organic matter included in the produced water using a biomass mixture of anaerobic bacteria obtained from a plurality of wells; aerating the recovered water in order to promote metal precipitation; and performing aerobic bio-digestion of organic matter present in the recovered water. Some embodiments may also include one or more of anoxic equalization, filtration, pasteurization, reverse osmosis, and biocide treatment of the recovered water. The recovered water may be used for oil and gas well fracking and/or land and stream application. Other methods of treating oil and gas produced water are also described.Type: GrantFiled: May 10, 2021Date of Patent: August 29, 2023Assignee: Rio Resources LLCInventors: Dale R. Yates, Brenna D. Villines, Kenneth M. Yates
-
Publication number: 20210269346Abstract: A method of treating oil and gas produced water may include: receiving produced water from one or more wells; separating an aqueous portion of the produced water from oil and solids included in the produced water in order to provide recovered water; performing anaerobic bio-digestion of organic matter included in the produced water using a biomass mixture of anaerobic bacteria obtained from a plurality of wells; aerating the recovered water in order to promote metal precipitation; and performing aerobic bio-digestion of organic matter present in the recovered water. Some embodiments may also include one or more of anoxic equalization, filtration, pasteurization, reverse osmosis, and biocide treatment of the recovered water. The recovered water may be used for oil and gas well fracking and/or land and stream application. Other methods of treating oil and gas produced water are also described.Type: ApplicationFiled: May 10, 2021Publication date: September 2, 2021Inventors: Dale R. Yates, Brenna D. Villines, Kenneth M. Yates
-
Publication number: 20210267929Abstract: An oral rinse including ionic silver as silver citrate complex and acemannan is useful for the treatment of oral ulceration and oral mucositis. The oral rinse has shown effectiveness against fungal and bacteria species such as Candida species, Staphylococcus aureus and Streptococcus pyogenes.Type: ApplicationFiled: July 2, 2019Publication date: September 2, 2021Applicant: CelaCare Technologies, Inc.Inventors: Kenneth M. Yates, Celia A. Proctor, Daniel H. Atchley
-
Patent number: 11001518Abstract: A method of treating oil and gas produced water may include: receiving produced water from one or more wells; separating an aqueous portion of the produced water from oil and solids included in the produced water in order to provide recovered water; performing anaerobic bio-digestion of organic matter included in the produced water using a biomass mixture of anaerobic bacteria obtained from a plurality of wells; aerating the recovered water in order to promote metal precipitation; and performing aerobic bio-digestion of organic matter present in the recovered water. Some embodiments may also include one or more of anoxic equalization, filtration, pasteurization, reverse osmosis, and biocide treatment of the recovered water. The recovered water may be used for oil and gas well fracking and/or land and stream application. Other methods of treating oil and gas produced water are also described.Type: GrantFiled: February 12, 2020Date of Patent: May 11, 2021Assignee: Rio Resources LLCInventors: Dale R. Yates, Brenna D. Villines, Kenneth M. Yates
-
Patent number: 10272108Abstract: An antimicrobial therapeutic hydrogel composition comprises a pharmaceutical and/or medical grade silver salt, and an Aloe vera gel or extract. The composition could also include stabilizing agents, a non-ionic surfactant, polyol, and hydrophilic hygroscopic polymers. The resulting product has potent antimicrobial activity against bacteria, protozoa, fungi and viruses. The antimicrobial therapeutic composition can serve as a treatment for burns and as a wound/lesion dressing that either donates or receives moisture to provide a physiologic environment for accelerated wound healing and the relief of pain.Type: GrantFiled: April 11, 2016Date of Patent: April 30, 2019Assignee: CELACARE TECHNOLOGIES, LLCInventors: Kenneth M Yates, Celia A Proctor, Dan H Atchley
-
Publication number: 20160243164Abstract: An antimicrobial therapeutic hydrogel composition comprises a pharmaceutical and/or medical grade silver salt, and an Aloe vera gel or extract. The composition could also include stabilizing agents, a non-ionic surfactant, polyol, and hydrophilic hygroscopic polymers. The resulting product has potent antimicrobial activity against bacteria, protozoa, fungi and viruses. The antimicrobial therapeutic composition can serve as a treatment for burns and as a wound/lesion dressing that either donates or receives moisture to provide a physiologic environment for accelerated wound healing and the relief of pain.Type: ApplicationFiled: April 11, 2016Publication date: August 25, 2016Applicant: CELACARE TECHNOLOGIES, LLCInventors: Kenneth M. Yates, Celia A. Proctor, Dan H. Atchley
-
Patent number: 9327029Abstract: An antimicrobial therapeutic hydrogel composition comprises a pharmaceutical and/or medical grade silver salt, and an Aloe vera gel or extract. The composition could also include stabilizing agents, a non-ionic surfactant, polyol, and hydrophilic hygroscopic polymers. The resulting product has potent antimicrobial activity against bacteria, protozoa, fungi and viruses. The antimicrobial therapeutic composition can serve as a treatment for burns and as a wound/lesion dressing that either donates or receives moisture to provide a physiologic environment for accelerated wound healing and the relief of pain.Type: GrantFiled: May 5, 2011Date of Patent: May 3, 2016Assignee: CelaCare Technologies, LLCInventors: Kenneth M. Yates, Celia A Proctor, Dan H Atchley
-
Publication number: 20120282348Abstract: An antimicrobial therapeutic hydrogel composition comprises a pharmaceutical and/or medical grade silver salt, and an Aloe vera gel or extract. The composition could also include stabilizing agents, a non-ionic surfactant, polyol, and hydrophilic hygroscopic polymers. The resulting product has potent antimicrobial activity against bacteria, protozoa, fungi and viruses. The antimicrobial therapeutic composition can serve as a treatment for burns and as a wound/lesion dressing that either donates or receives moisture to provide a physiologic environment for accelerated wound healing and the relief of pain.Type: ApplicationFiled: May 5, 2011Publication date: November 8, 2012Inventors: Kenneth M. Yates, Celia A. Proctor, Dan H Atchley
-
Patent number: 7705135Abstract: Pectins having a combination of unexpectedly high molecular weights and low degrees of methylation have been isolated from Aloe vera plants, are superior gel pectins for forming calcium cross-lined gels. Such pectins can be obtained by extracting homogenized Aloe Vera plants or portions thereof. These pectins can be used to prepare pharmaceutical compositions comprising pharmacological agents for application to animals and humans, so as to provide controlled release of the pharmacological agent.Type: GrantFiled: May 19, 2006Date of Patent: April 27, 2010Assignee: Nanotherapeutics, Inc.Inventors: Yawei Ni, Kenneth M. Yates, Ryszard Zarzycki
-
Patent number: 7691986Abstract: Pectins having a combination of unexpectedly high molecular weights and low degrees of methylation have been isolated. These high molecular weight, low degree of methylation pectins form gels at unexpectedly low concentrations. Such pectins can be obtained by extracting homogenized Aloe Vera plants or portions thereof. These pectins can be used to prepare pharmaceutical compositions comprising pharmacological agents encapsulated in a pectin gel, for application to animals and humans so as to provide controlled release of the pharmacological agent.Type: GrantFiled: April 23, 2003Date of Patent: April 6, 2010Assignee: Nanotherapeutics, Inc.Inventors: Yawei Ni, Kenneth M. Yates, Ryszard Zarzycki
-
Patent number: 7494669Abstract: In-situ gelation of a pectic substance. Composition, method of preparation, and method of use of a pectin in-situ gelling formulation for the delivery and sustained release of a physiologically active agent to the body of an animal. The pectin can be isolated from Aloe vera.Type: GrantFiled: August 29, 2003Date of Patent: February 24, 2009Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates
-
Patent number: 7202066Abstract: A composition combining an extracellular matrix-degrading protease and a growth factor related to epithelial cell functions together without inactivation or degradation of the growth factor by the protease. Preferably, the protease is plasmin/plasminogen or a related one, and the growth factor is KGF or a related one. The combination associates two independent, but synergistic functions essential to the re-epithelialization process or healing process, i.e, stimulating epithelial cell proliferation/differentiation and facilitating its migration by clearing the extracellular matrix components. The combination may be constructed in various ways and can be used to treat wounds or any other disease conditions involving cells of epithelial origin or any other cell types that the growth factor may affect.Type: GrantFiled: January 29, 2002Date of Patent: April 10, 2007Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates
-
Patent number: 7022683Abstract: The inventions disclosed herein relate to compositions for the sustained release of pharmacological agents comprising pectins having a combination of both a high molecular weight and a low degree of methoxylation.Type: GrantFiled: June 3, 1999Date of Patent: April 4, 2006Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates, Ryszard Zarzycki
-
Patent number: 6777000Abstract: In-situ gelation of a pectic substance. Composition, method of preparation, and method of use of a pectin in-situ gelling formulation for the delivery and sustained release of a physiologically active agent to the body of an animal. The pectin can be isolated from Aloe vera.Type: GrantFiled: February 28, 2001Date of Patent: August 17, 2004Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates
-
Publication number: 20030220485Abstract: Pectins having a combination of unexpectedly high molecular weights and low degrees of methylation have been isolated. These high molecular weight, low degree of methylation pectins form gels at unexpectedly low concentrations. Such pectins can be obtained by extracting homogenized Aloe Vera plants or portions thereof. These pectins can be used to prepare pharmaceutical compositions comprising pharmacological agents encapsulated in a pectin gel, for application to animals and humans so as to provide controlled release of the pharmacological agent.Type: ApplicationFiled: April 23, 2003Publication date: November 27, 2003Applicant: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates, Ryszard Zarzycki
-
Publication number: 20030175370Abstract: Substantially dry mixture having solid-containing complex carbohydrate and a water-soluble pharmaceutical auxiliary is dispersible in water. The dry mixture can also contain simple sugar and starch. A dispersible, or soluble, mixture having solid-containing complex carbohydrate, originated or derived from a processed plant, and processes of preparation of the mixture. The processed plant can be Aloe vera.Type: ApplicationFiled: March 7, 2002Publication date: September 18, 2003Applicant: Carrington Laboratories, Inc.Inventors: Kenneth M. Yates, Dongmei Wang, John Long
-
Publication number: 20030147876Abstract: A composition combining an extracellular matrix-degrading protease and a growth factor related to epithelial cell functions together without inactivation or degradation of the growth factor by the protease. Preferably, the protease is plasmin/plasminogen or a related one, and the growth factor is KGF or a related one. The combination associates two independent, but synergistic functions essential to the re-epithelialization process or healing process, i.e, stimulating epithelial cell proliferation/differentiation and facilitating its migration by clearing the extracellular matrix components. The combination may be constructed in various ways and can be used to treat wounds or any other disease conditions involving cells of epithelial origin or any other cell types that the growth factor may affect.Type: ApplicationFiled: January 29, 2002Publication date: August 7, 2003Applicant: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates
-
Publication number: 20020119941Abstract: In-situ gelation of a pectic substance. Composition, method of preparation, and method of use of a pectin in-situ gelling formulation for the delivery and sustained release of a physiologically active agent to the body of an animal. The pectin can be isolated from Aloe vera.Type: ApplicationFiled: February 28, 2001Publication date: August 29, 2002Inventors: Yawei Ni, Kenneth M. Yates
-
Patent number: 6313103Abstract: Pectic substance from Aloe Vera and other sources is used as a stabilizer and a delivery vehicle for pectin/heparin-binding proteins, such as pectin/heparin binding growth factors. Aloe pectin, a naturally occurring LM (low methoxyl) pectin, binds to pectin/heparin-binding growth factors, i.e., bFGF, aFGF, and KGF of fibroblast growth factor (FGF) family and TGF-&bgr;1 of transforming growth factor-&bgr; (TGF-&bgr;) family. Commercial LM or HM (high methoxyl) citrus pectins tested did not exhibit any binding activity with bFGF. A weak binding to bFGF was observed with a de-esterified pectin (polygalacturonic acid) prepared from citrus. The binding protected the growth factor from protease digestion. The calcium gel beads prepared with Aloe pectin also bound to these pectin/heparin-binding growth factors. The growth factor could also be encapsulated in the pectin calcium gel and Aloe pectin sodium gel. Pectin/heparin-binding growth factor stabilized by pectin is used for wound healing.Type: GrantFiled: July 24, 1998Date of Patent: November 6, 2001Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates
-
Patent number: 6274548Abstract: Pectic substance from Aloe Vera and other sources is used as a stabilizer and a delivery vehicle for pectin/heparin-binding proteins, such as pectin/heparin binding growth factors. Aloe pectin, a naturally occurring LM (low methoxyl) pectin, binds to pectin/heparin-binding growth factors, i.e., bFGF, aFGF, and KGF of fibroblast growth factor (FGF) family and TGF-&bgr;1 of transforming growth factor-&bgr; (TGF-&bgr;) family. Commercial LM or HM (high methoxyl) citrus pectins tested did not exhibit any binding activity with bFGF. A weak binding to bFGF was observed with a de-esterified pectin (polygalacturonic acid) prepared from citrus. The binding protected the growth factor from protease digestion. The calcium gel beads prepared with Aloe pectin also bound to these pectin/heparin-binding growth factors. The growth factor could also be encapsulated in the pectin calcium gel and Aloe pectin sodium gel. Pectin/heparin-binding growth factor stabilized by pectin is used for wound healing.Type: GrantFiled: June 4, 1999Date of Patent: August 14, 2001Assignee: Carrington Laboratories, Inc.Inventors: Yawei Ni, Kenneth M. Yates